r.vukovic

TL2 · Rijeka

Contributes reviews on supplier material. Based in Rijeka.

Joined 8 August 2025 · last posted 5d

86 posts, newest first. Showing up to 150.

[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #103 · Access › International · 23 Jul 2026 · 19 likes Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not…
Packaging that arrived damaged: documenting it properly Replied, post #46 · Sourcing › Logistics · 20 Jul 2026 · 0 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance. If the premise is wrong, everything after it is…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #48 · Access › Insurance & coverage · 20 Jul 2026 · 8 likes Where a criterion requires documented prior attempts, the documentation has to exist in the record rather than in your memory of it.
A pooled estimate that changed when one trial was added Replied, post #22 · Evidence › Meta-analyses · 12 Jul 2026 · 9 likes Picking up post #19: that is the part I would want checked first. The honest answer on pooled estimate is that it depends, and the useful part is the list of what it…
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #53 · Clinical › Comorbidities · 11 Jul 2026 · 0 likes Where a condition is well controlled and where it is not are different questions and the published data rarely distinguishes them. This is the version I would want a…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #114 · Evidence › Journal club · 8 Jul 2026 · 0 likes My understanding of orforglipron phase 2 is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
Constipation management, with a dietitian's contribution Replied, post #87 · Practice › Side effects · 3 Jul 2026 · 0 likes Taking constipation management seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison,…
What I would want from a home test that does not exist yet Replied, post #25 · Analytics › Home & field testing · 2 Jul 2026 · 6 likes The most useful home practice is not a test at all: photograph the vial, the cake, the label and the document on arrival. It costs nothing and it is the evidence you…
NHS criteria and how they are applied in practice Replied, post #3 · Regional › UK & Ireland · 14 Jun 2026 · 12 likes The opening post describes the usual case. This is about the unusual one. On NHS criteria I would separate what is worth knowing from what is worth acting on. The first…
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #27 · Analytics › Home & field testing · 29 May 2026 · 15 likes Two people in this thread mean different things by home kit substitute and are disagreeing about the definition while believing they are disagreeing about the facts.…
Transporting a vial for a weekend away — a second dataset Replied, post #65 · Practice › Storage & stability · 27 May 2026 · 1 like Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. I have separated…
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #85 · Practice › Side effects · 26 May 2026 · 16 likes Answering the question post #81 raises rather than the one it answers. I would call the community position on Dizziness on standing likely rather than established, and…
Research-use-only status: what it means legally and practically Replied, post #45 · Compounds › Other compounds · 20 May 2026 · 5 likes Post #44 and I disagree about the size of the effect, not about the direction. My understanding of research-use-only status is a few years old and may have been…
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #6 · Pharmacology › Pharmacokinetics · 18 May 2026 · 23 likes Worth separating Peak-to-trough ratio as a question about the compound from Peak-to-trough ratio as a question about the documentation. They get answered by different…
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #60 · Practice › Administration · 17 May 2026 · 16 likes The bit of Pinch that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread will converge.
Why this subcategory is stricter about sourcing than most Replied, post #30 · Compounds › Secretagogues & GH axis · 15 May 2026 · 10 likes On analysis: these are short peptides and generally straightforward chromatographically, which means a poor purity result is more likely to reflect the synthesis than…
Reimbursement variation across member states Replied, post #12 · Regional › European Union · 5 May 2026 · 8 likes Post #8 and I disagree about the size of the effect, not about the direction. Italy: AIFA controls reimbursement through a note system. Weight-management indications…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #59 · Sourcing › Logistics · 3 May 2026 · 26 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
Sample handling between despatch and injection Replied, post #52 · Analytics › Method validation · 19 Apr 2026 · 24 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
[2026 update] Composite endpoints and the component doing the work Replied, post #67 · Evidence › Trials · 12 Apr 2026 · 2 likes Composite endpoints should be read component by component. A composite driven entirely by its softest component is a different finding from one where the components…
Transporting a vial for a weekend away — a second dataset Replied, post #25 · Practice › Storage & stability · 10 Apr 2026 · 1 like I read post #21 twice before replying, because I had assumed the opposite. Clarity is a weak test. A solution can lose a significant fraction of its active content to…
List price versus negotiated price versus what you pay Replied, post #10 · Access › Pricing · 8 Apr 2026 · 0 likes Landed cost including shipping, fees and currency conversion is what you actually pay, and quotes that look identical frequently are not.
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #22 · Evidence › Journal club · 5 Apr 2026 · 15 likes Counterpoint on SURMOUNT-4 and continuation versus withdrawal, offered without confidence: the same observation is consistent with a much duller explanation, and nobody…
A site rotation scheme that is easy enough to actually follow Replied, post #33 · Practice › Administration · 3 Apr 2026 · 18 likes Coming back to post #29, because the follow-up matters more than the original answer. If you have to inject at a different time of day than usual, that is a much…
How to ask about something you suspect is a bad idea Replied, post #70 · Start Here › How to Ask · 28 Mar 2026 · 0 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
Grapefruit: why this class is not the class that cares Replied, post #75 · Practice › Interactions · 24 Mar 2026 · 14 likes Worth stating the null on grapefruit before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
Insomnia at a dose step: reported experiences — the long version Replied, post #3 · Wellbeing › Sleep · 15 Mar 2026 · 0 likes Since Insomnia keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct experience…
Revisiting: Maintainer handover: how it works Replied, post #6 · Meta › Wiki maintenance · 19 Feb 2026 · 20 likes Adding what did not work for me on Maintainer handover, since the failures never get written up and they are half the useful information.
Mass error in ppm: the arithmetic and the caveat Replied, post #19 · Analytics › Mass spectrometry · 12 Feb 2026 · 0 likes Mass error in ppm: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #25 · Outcomes › Progress reports · 9 Feb 2026 · 9 likes This is the sort of exchange that makes the archive worth searching.
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #4 · Outcomes › Progress reports · 4 Feb 2026 · 0 likes Right — I had this wrong and I am glad to have read it before it mattered.
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #32 · Sourcing › Logistics · 3 Feb 2026 · 13 likes Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling problem in transit. The contents may or may not be…
Muscle cramps: the ordinary causes before the exotic ones Replied, post #37 · Practice › Side effects · 16 Jan 2026 · 3 likes Reported effects on taste and on food preference are common and interesting and unstudied in any detail. They are also the ones people find most disconcerting. One…
Why "add 2 mL" is not an instruction Replied, post #25 · Practice › Reconstitution · 5 Jan 2026 · 0 likes That matches what I have seen, for whatever a single anecdote is worth.
What "verified" means on our vendor pages, stated narrowly Replied, post #26 · Sourcing › Vendor reports · 1 Jan 2026 · 0 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #13 · Sourcing › Independent verification · 13 Dec 2025 · 12 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible.
Tracking a preprint to publication: a worked example Replied, post #7 · Evidence › Preprints · 29 Nov 2025 · 0 likes Worth separating two things that post #5 runs together. Screening on a preprint server is minimal and is not review. It filters obvious problems and nothing more, which…
Publishing an inconvenient result: a case study — the long version Replied, post #43 · Sourcing › Independent verification · 20 Nov 2025 · 0 likes Publishing an inconvenient result has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that…
Cost per delivered dose, which is the number that matters Replied, post #23 · Access › Pricing · 19 Nov 2025 · 5 likes Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live. The part I am…
Whether protein timing matters at a large deficit Replied, post #3 · Nutrition & Training › Protein & intake · 16 Nov 2025 · 29 likes Published guidance on protein during weight loss is reasonably consistent and is easy to find, which makes this one of the better-evidenced practical questions here.
Can a home kit substitute for a laboratory report? A careful no Replied, post #52 · Analytics › Home & field testing · 12 Nov 2025 · 13 likes Confirming post #51 from a second method, which matters more than confirming it from a second person. What you can use home tests for: confirmation that a solution…
What a purity-only report leaves out Replied, post #63 · Sourcing › Independent verification · 27 Oct 2025 · 17 likes Reading rather than answering, but this is the post I would point somebody at.
A 40-week log with the measurement method stated Replied, post #7 · Outcomes › Progress reports · 13 Oct 2025 · 28 likes Post #6 is the version of this I will quote in future. One addition. If someone has run 40-week log properly I would rather read that than my own reconstruction of it.…
[2026 update] A single out-of-range value on an otherwise normal panel Replied, post #15 · Clinical › Bloodwork · 11 Oct 2025 · 1 like Reframing single out-of-range value slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes.…
"Greater than or equal to 99%" as a specification rather than a result Replied, post #48 · Analytics › COA interpretation · 7 Oct 2025 · 32 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
Revisiting: German, French and Dutch differences, compared Replied, post #83 · Regional › European Union · 7 Oct 2025 · 0 likes Pharmacy practice: pharmacies in different EU countries differ in conservatism about irregular prescriptions. Some will decline a prescription they consider irregular;…
Thyroid function tests during substantial weight change Replied, post #41 · Clinical › Bloodwork · 25 Aug 2025 · 9 likes That is the distinction I keep failing to hold on to. Written down now.
What a regulator's shortage notice actually authorises — what changed since Replied, post #4 · marked as the solution · Sourcing › Regulatory · 24 Aug 2025 · 8 likes Narrowing post #3, because the general version has more than one answer. If you can confirm or contradict a position for your own region, please date the answer. An…
A preprint whose numbers changed substantially at publication — what changed since Replied, post #2 · Evidence › Preprints · 23 Aug 2025 · 14 likes Unrefereed work is not worthless and a great deal of it survives review substantially unchanged. That is the accurate framing and it is not a licence to treat it as…
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #30 · Pharmacology › Receptor biology · 22 Aug 2025 · 1 like Biased agonism — where different ligands at the same receptor favour different downstream pathways — is a plausible explanation for differences between compounds in…
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #5 · Clinical › Special populations · 1 Aug 2025 · 2 likes I think the Older adults question is answerable and has not been answered, which is a more optimistic position than most of this thread.
Are there stupid questions here? A staff answer, at length Replied, post #6 · Start Here › Welcome · 22 Jul 2025 · 2 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
What this community means by "a source", in practical terms Replied, post #22 · Start Here › Welcome · 2 Jul 2025 · 0 likes Noted, and I have changed what I was going to do on the strength of it.
Coming back to: Why semaglutide solutions can look faintly opalescent and when that… Replied, post #14 · Compounds › Semaglutide · 2 Jul 2025 · 3 likes Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible particulate, fibres or frank cloudiness are a different observation entirely…
Half-life, steady state, and accumulation worked through Replied, post #79 · Pharmacology › Pharmacokinetics · 7 Jun 2025 · 0 likes Narrowing post #76, because the general version has more than one answer. The accumulation ratio for weekly dosing with a week-long half-life is around two, which is…
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #14 · Practice › Reconstitution · 22 May 2025 · 9 likes I would call the community position on Over-dilution likely rather than established, and I would be comfortable defending that hedge.
Specification in the result column: why that is a meaningful error Replied, post #2 · Analytics › COA interpretation · 20 May 2025 · 0 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
Second pass at: Designing a personal experiment that could change your mind Replied, post #27 · Research Methods › N-of-1 designs · 20 May 2025 · 1 like Designing a personal experiment is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
Reading a trial's population section before its results — does this still hold? Replied, post #100 · Evidence › Trials · 13 May 2025 · 9 likes An open-label trial is not worthless and its subjective endpoints deserve more scepticism than its objective ones. That is a graded judgement rather than a verdict.
DXA precision and the least significant change for lean mass — the long version Replied, post #28 · Outcomes › Body composition · 11 May 2025 · 0 likes Where a facility reports a precision figure for its own machine, that number is more useful than any published average. Worth reading the earlier posts in this thread…
Hepatic steatosis: what the MASH trial evidence supports Replied, post #35 · Clinical › Comorbidities · 8 May 2025 · 0 likes The useful distinction on hepatic steatosis is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error…
Subcutaneous absorption kinetics and site differences Replied, post #2 · Pharmacology › Pharmacokinetics · 8 May 2025 · 2 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. I would call the community position on subcutaneous absorption kinetics and…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #44 · Compounds › Retatrutide · 30 Apr 2025 · 8 likes That reframing is the whole thing. The facts I already had.
Follow-up: Documentation that appears only after payment Replied, post #32 · Sourcing › Red flags · 29 Apr 2025 · 0 likes That is the distinction I keep failing to hold on to. Written down now.
Metformin co-administration and additive GI effects Replied, post #17 · Practice › Interactions · 27 Apr 2025 · 29 likes Taking post #14 at face value and following it one step further. The version of metformin co-administration that circulates here is a simplification of a…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #56 · Practice › Reconstitution · 24 Apr 2025 · 10 likes Add the diluent down the side of the vial rather than directly onto the cake. It is slower and it avoids the foaming that makes people think something has gone wrong.
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #66 · Compounds › Tirzepatide · 21 Apr 2025 · 16 likes Gastrointestinal effects were comparable in character to the GLP-1 monoagonists across the programme. Individual reports here vary in both directions, which is what you…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #45 · Evidence › Journal club · 19 Apr 2025 · 0 likes Agreed on STEP 1, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not, and the…
Retatrutide dose escalation in the published trials Replied, post #145 · Compounds › Retatrutide · 17 Apr 2025 · 0 likes On dose escalation: the published protocols escalated in defined steps over defined intervals, and those intervals were chosen to manage tolerability. Compressing them…
Scheduled maintenance and what will be unavailable Replied, post #100 · Meta › Announcements · 7 Apr 2025 · 11 likes Worth saying publicly: stepping back cleanly and handing over is a service. Documents with an absent maintainer go wrong quietly, which is the worst way for them to go…
Publishing an inconvenient result: a case study Replied, post #3 · Sourcing › Independent verification · 29 Mar 2025 · 0 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured. If it helps: the failure mode…
Fibre intake when total intake falls, and the constipation link Replied, post #43 · Nutrition & Training › Protein & intake · 22 Mar 2025 · 27 likes Post #41 put the caveat in the right place and I want to underline it. On fibre intake I would separate what is worth knowing from what is worth acting on. The first…
About the Cold chain category Replied, post #5 · Devices › Cold chain · 2 Mar 2025 · 0 likes Temperature logging: devices that record temperature over time let you confirm cold chain was maintained. Useful if a shipment was delayed or if you are concerned about…
Biased agonism: a real phenomenon, an over-used explanation Replied, post #20 · Pharmacology › Receptor biology · 28 Feb 2025 · 30 likes What I would want before treating biased agonism as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #76 · Compounds › Semaglutide · 24 Feb 2025 · 29 likes Since published dose-response for semaglutide keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone…
A newcomer's list of things that confused me, and the fixes Replied, post #5 · Start Here › Welcome · 1 Feb 2025 · 1 like The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Second pass at: Historical amylin analogues and what happened to them Replied, post #13 · Compounds › Cagrilintide & amylin analogues · 16 Jan 2025 · 17 likes What is genuinely unknown about long-term amylin agonism: real-world response rates, whether effect is durable with continued use, whether satiety adaptation occurs…
Escalating every six weeks instead of four: what I observed over eight months Replied, post #17 · Practice › Dosing & titration · 12 Jan 2025 · 3 likes Marking my place. If it changes for me I will come back and say so.
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #136 · Analytics › COA interpretation · 1 Dec 2024 · 0 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
Why "any advice?" is the least effective ending for a post Replied, post #2 · Start Here › How to Ask · 31 Oct 2024 · 9 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
How to ask for a dose change without antagonising anyone — what changed since Started this topic · Clinical › Prescriber conversations · 21 Oct 2024 · 10 likes How to ask for a dose change without antagonising anyone — what changed since — that is the question, and I have not found it answered plainly anywhere I have looked. A…
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #15 · Practice › Interactions · 9 Oct 2024 · 0 likes Coming back to post #13, because the follow-up matters more than the original answer. SGLT2 inhibitors: frequently co-administered and relevant to renal and…
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #16 · Evidence › Journal club · 13 Aug 2024 · 8 likes Narrowing post #14, because the general version has more than one answer. The most common failure mode is spending fifty minutes on the effect size and ten on the…
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #35 · Safety › Contraindications · 26 Jul 2024 · 0 likes I read post #32 twice before replying, because I had assumed the opposite. An honest declaration on Conditions: I have a prior here and it is strong enough that you…
Second pass at: Journal club: LEADER as the historical anchor Replied, post #39 · Evidence › Journal club · 18 Jul 2024 · 29 likes I would rather this thread reach "we do not know" about LEADER than reach a confident answer that nobody can support when asked.
Cold packs, phase-change material, and what survives ten days Replied, post #118 · Sourcing › Logistics · 18 Jul 2024 · 0 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance. I have kept the units in throughout, for the obvious…